Exagen inc. expands coverage with inland empire health plan, partnering to provide more accurate diagnostic testing with avise® ctd and avise lupus

San diego, oct. 27, 2021 (globe newswire) -- exagen inc. (nasdaq: xgn), a leading provider of autoimmune testing solutions, announced today that avise® ctd and avise lupus are a contracted covered service with inland empire health plan (iehp), providing enhanced care to over 1.4 million members. the agreement also makes avise diagnostic testing available as an in-network benefit.
XGN Ratings Summary
XGN Quant Ranking